148 related articles for article (PubMed ID: 12812134)
1. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.
Galli J; Scarano S; Agostino S; Quaranta N; Cammarota G; Ottaviani F
Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):38-42. PubMed ID: 12812134
[TBL] [Abstract][Full Text] [Related]
2. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
3. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
Pace F; Bollani S; Molteni P; Bianchi Porro G
Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
[TBL] [Abstract][Full Text] [Related]
4. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
7. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
Vakil N
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
[TBL] [Abstract][Full Text] [Related]
8. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
Hirano I
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of gastro-oesophageal reflux disease.
De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
[TBL] [Abstract][Full Text] [Related]
13. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.
Gatta L; Vaira D; Sorrenti G; Zucchini S; Sama C; Vakil N
Aliment Pharmacol Ther; 2007 Feb; 25(4):385-92. PubMed ID: 17269993
[TBL] [Abstract][Full Text] [Related]
15. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
16. Empiric therapy for gastroesophageal reflux disease.
Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
[TBL] [Abstract][Full Text] [Related]
17. Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.
Wong CH; Chua CJ; Liam CK; Goh KL
Aliment Pharmacol Ther; 2006 May; 23(9):1321-7. PubMed ID: 16629937
[TBL] [Abstract][Full Text] [Related]
18. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.
Bretagne JF; Honnorat C; Richard-Molard B; Caekaert A; Barthélemy P
Aliment Pharmacol Ther; 2006 Mar; 23(5):607-16. PubMed ID: 16480400
[TBL] [Abstract][Full Text] [Related]
20. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]